Synthetic biology tackles global antivenom shortage.
Carrie
C
Arnold
D000818:Animals; D000918:Antibody Specificity / Q000276:immunology; D000997:Antivenins / Q000096:biosynthesis* / Q000191:economics / Q000235:genetics / Q000276:immunology; D006736:Horses / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D051379:Mice; D012909:Snake Bites / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D012910:Snake Venoms / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000276:immunology; D058615:Synthetic Biology / Q000379:methods* / Q000639:trends*
D000997:Antivenins; D012910:Snake Venoms